Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports
Dermatology Online Journal · 2024
DOI: 10.5070/d330163287 ↗Kurz gefasst
Fallbericht in der Zeitschrift Dermatology Online Journal, 2024. Verfasst von Philip R Cohen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of California Davis Health, Sacramento, California, USA Touro University California College of Osteopathic Medi…. Hauptthemen laut MEDLINE: Muir-Torre Syndrome, Germ-Line Mutation, DNA Mismatch Repair, Immunosuppressive Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of California Davis Health, Sacramento, California, USA Touro University California College of Osteopathic Medicine, Vallejo, California, USA. mitehead@gmail.com.
Zitieren
APA
Cohen, P. R., & Kurzrock, R. (2024). Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports. Dermatology Online Journal. https://doi.org/10.5070/d330163287
Vancouver
Cohen PR, Kurzrock R. Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports. Dermatology Online Journal. 2024. doi:10.5070/d330163287
BibTeX
@article{Cohen2024,
author = {Cohen, Philip R and Kurzrock, Razelle},
title = {Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports},
journal = {Dermatology Online Journal},
year = {2024},
doi = {10.5070/d330163287}
}
EUVIMED